The investigators used the multicenter COPDGene dataset, analyzing 8,383 participants to test whether central airway shape relates to clinical outcomes. They measured tracheal lumen geometry on axial CT slices and defined a per-participant eccentricity (ϵ) as the arithmetic mean across all tracheal cross-sections. By definition, ϵ = 0 denotes a circular lumen; values approaching 1 indicate increasingly elongated ellipses. The manuscript reports that mean eccentricity increased stepwise across GOLD stages 0 through 4, with group means reported in the Abstract. The study team adjusted all models for age, sex, race, BMI, smoking status, pack-years, and scanner model.
The metric itself—derived from major and minor axis lengths on CT—was applied consistently across slices and participants. The report did not include additional methodological specifics about slice selection criteria, gating, or inter-reader reproducibility in the Abstract; those details were not reported in the provided text. Ethical oversight was obtained from the University of Alabama at Birmingham IRB (IRB-170125002), and the authors stated that participant consent procedures were completed.
Higher tracheal eccentricity correlated with worse cross-sectional clinical measurements. Data indicated that greater eccentricity was independently associated with lower FEV1 (β = -0.30 L) and lower FEV1/FVC (β = -0.06) after covariate adjustment. The cohort showed declines in functional performance tied to eccentricity: 6-minute walk distance fell (β = -15.7 m) and health-related quality of life worsened as reflected by higher St. George's Respiratory Questionnaire scores (β = 16.9). The authors also observed a statistically significant association with dyspnea severity using the mMRC scale (β = 0.4).
The models reported were multivariable linear regressions incorporating demographic and exposure covariates plus scanner model. The text presented effect estimates with confidence intervals and p-values in the Abstract; investigators therefore concluded that eccentric tracheal geometry paralleled multiple markers of respiratory morbidity. The paper did not report in the Abstract whether subgroup analyses (for example by emphysema phenotype or airway-predominant disease) were performed or how eccentricity compared with other CT airway measurements.
The study extended its analysis to longitudinal outcomes. Data indicated accelerated lung function loss associated with higher eccentricity—an annualized FEV1 decline estimate of β = -23.8 mL/year was reported. The authors also described a relationship between eccentricity and all-cause mortality: an adjusted hazard ratio of 1.81 (95% CI 1.01–3.26) appeared in their Cox model.
These longitudinal associations were adjusted for the same covariates used in cross-sectional models. The Abstract specifies the direction and magnitude of the associations along with statistical significance thresholds, but it did not provide the number of events, duration of follow-up, or cause-specific mortality breakdown in the excerpt available. The analysis therefore signals an independent association between central airway morphology and hard outcomes, as observed by the study team.
This report is a medRxiv preprint and has not undergone peer review; the authors stated that the findings should not be used to guide clinical practice. The Abstract contained effect sizes, confidence intervals, and p-values but did not supply trial-level details such as intra- and inter-reader variability for eccentricity measurements, prospective validation in an independent cohort, or the exact follow-up interval and event counts for mortality. Those methodological gaps were not reported in the provided text.
The authors declared no competing interests and confirmed adherence to ethical guidelines. They noted that all data produced are available on reasonable request and that the manuscript contains the primary data produced in the work. The University of Alabama at Birmingham IRB approved the study (IRB-170125002), as reported by the authors.
Open questions remain. The study team framed tracheal lumen eccentricity as a candidate imaging biomarker for COPD outcomes, but the Abstract did not report external validation, standardized measurement protocols for clinical use, or thresholds for risk stratification. Future peer review and additional reporting—providing reproducibility metrics, follow-up duration, event counts, and potential phenotype-specific effects—will be necessary before clinical translation.
Data availability statements within the manuscript indicate that interested investigators may request access to the underlying data. The preprint DOI and author contact details are provided in the paper for follow-up and verification.